Australia
Austria
Belgium
China
Czech Republic
Denmark
Estonia
Finland
France
Germany
Hungary
India
Ireland
Italy
Japan
Kazakhstan
Latvia
Lithuania
Malaysia
Netherlands
Norway
Poland
Singapore
Slovenia
Spain
Sweden
Thailand
UK
Ukraine
Investors
This section contains information about Orion as an investment.
Stock exchange releases
- 12/19/2024 CORRECTION: Change in Orion Group Executive Management Board as of 1 June 2025 – Mikko Kemppainen appointed General Counsel
- 12/19/2024 Change in Orion Group Executive Management Board as of 1 June 2025 – Mikko Kemppainen appointed General Counsel
- 12/12/2024 Penalty payment to a member of Orion’s Board of Directors for delay in notifying managers’ transaction
- 11/27/2024 142,701 Orion Corporation A shares converted into B shares
Press releases
- 12/18/2024 Orion and Abilita Therapeutics announce research collaboration and option to license agreement to develop innovative antibody therapeutics
- 11/22/2024 Orion Research Foundation grants EUR 1,109,000 for research in 2025
- 11/19/2024 Orion and Alligator Bioscience amend their agreement concerning two bispecific antibodies
- 10/15/2024 Orion publishes Interim Report for January–September 2024 and holds a webcast on 29 October 2024
